Abstract
Purpose
Volumetric liver fat fraction (VLFF) measurements were made using the HepaFat-Scan® technique at 1.5T and 3T to determine the agreement between the measurements obtained at the two fields.
Methods
Sixty patients with type 2 diabetes (67% male, mean age 50.92 ± 6.56yrs) and thirty healthy volunteers (50% male, mean age 48.63 ± 6.32yrs) were scanned on 1.5T Aera and 3T Skyra (Siemens, Erlangen, Germany) MRI scanners on the same day using the HepaFat-Scan® gradient echo protocol with modification of echo times for 3T (TEs 2.38, 4.76, 7.14 ms at 1.5T and 1.2, 2.4, 3.6 ms at 3T). The 3T analyses were performed independently of the 1.5T analyses by a different analyst, blinded from the 1.5T results. Data were analysed for agreement and bias using Bland-Altman methods and intraclass correlation coefficients (ICC). A second cohort of 17 participants underwent interstudy repeatability assessment of VLFF measured by HepaFat-Scan® at 3T.
Results
A small, but statistically significant mean bias of 0.48% was observed between 3T and 1.5T with 95% limits of agreement -2.2% to 3.2% VLFF. The ICC for agreement between field strengths was 0.983 (95% CI 0.972–0.989). In the repeatability cohort studied at 3T the repeatability coefficient was 4.2%. The ICC for agreement was 0.971 (95% CI 0.921–0.989).
Conclusion
There is minimal bias and excellent agreement between the measures of VLFF using the HepaFat-Scan® at 1.5 and 3T. The test retest repeatability coefficient at 3T is comparable to the 95% limits of agreement between 1.5T and 3T suggesting that measurements can be made interchangeably between field strengths.
Funder
National Institute for Health Research
British Heart Foundation
Publisher
Public Library of Science (PLoS)
Reference26 articles.
1. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.;European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O;J Hepatol,2016
2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;G Vernon;Aliment Pharmacol Ther,2011
3. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;GC Farrell;Hepatology,2006
4. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data;F Negro;Liver Int,2009
5. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity;E Fabbrini;Proc Natl Acad Sci U S A,2009
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献